Rezolute Medical Affairs
@rzltmedaffairs.bsky.social
As representatives of a rare disease biotech company, we’re committed to connecting with healthcare professionals and advocates to foster transparent, meaningful conversations in the rare disease space.
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
November 10, 2025 at 10:39 PM
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
We applaud Congenital Hyperinsulinism International, the authors, and—most importantly—the patients and families—for their groundbreaking, innovative study on the real-world experience of diazoxide in congenital hyperinsulinism. #MedSky #EndoSky #PedSky #CongenitalHI #Hyperinsulinism
August 23, 2025 at 12:10 AM
We applaud Congenital Hyperinsulinism International, the authors, and—most importantly—the patients and families—for their groundbreaking, innovative study on the real-world experience of diazoxide in congenital hyperinsulinism. #MedSky #EndoSky #PedSky #CongenitalHI #Hyperinsulinism
📈ICYMI we presented Preliminary Patient Demographics And Baseline Characteristics from Phase 3 Study #sunRIZE of Ersodetug for Hypoglycemia due to #CongenitalHI at #ENDO2025
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
July 25, 2025 at 6:13 PM
📈ICYMI we presented Preliminary Patient Demographics And Baseline Characteristics from Phase 3 Study #sunRIZE of Ersodetug for Hypoglycemia due to #CongenitalHI at #ENDO2025
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
📎 View the full poster here: bit.ly/416Pdt5
🙏Thank you to all who stopped by and engaged with us
#EndoSky #MedSky #Ph3 #RZLT
Proud to present "Preliminary Patient Demographics and Baseline Characteristics From a Phase 3 Study (sunRIZE) of Ersodetug for Hypoglycemia Due to Congenital Hyperinsulinism: Trial in Progress" today at #ENDO2025. View the full poster here: bit.ly/44x4GF6 #EndoSky #MedSky #CongenitalHi #RZLT
July 14, 2025 at 11:07 PM
Proud to present "Preliminary Patient Demographics and Baseline Characteristics From a Phase 3 Study (sunRIZE) of Ersodetug for Hypoglycemia Due to Congenital Hyperinsulinism: Trial in Progress" today at #ENDO2025. View the full poster here: bit.ly/44x4GF6 #EndoSky #MedSky #CongenitalHi #RZLT
🎗️ Today June 7th is Global Hyperinsulinism Awareness Day 🎗️Rezolute proudly stands with the incredible HI advocacy community who inspire our work every day.
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
June 7, 2025 at 7:10 AM
🎗️ Today June 7th is Global Hyperinsulinism Awareness Day 🎗️Rezolute proudly stands with the incredible HI advocacy community who inspire our work every day.
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)